Pfizer: 200M more vaccine doses for US by April 2022
Pfizer Inc. Chief Executive Officer (CEO) Albert Bourla announced on Friday that his company and its partner BioNTech SE will deliver 200 million more doses of their vaccine against COVID-19 to the United States by April 2022.
“More doses to help expand protection in the US,” Bourla tweeted. “We are very proud to be a long-term partner to the US government and to help ensure broad vaccine access across the country into next year.”
The two companies recently stated they are hoping their vaccine will get the US Food and Drug Administration’s (FDA) full approval by January 2022.
Get involved!
Comments